C-Phycocyanin protects SH-SY5Y cells from oxidative injury, rat retina from transient ischemia and rat brain mitochondria from Ca2+/phosphate-induced impairment  by Marín-Prida, Javier et al.
RC
t
i
J
K
A
S
a
b
c
d
1
e
R
a
A
R
R
A
A
K
C
S
T
R
A
N
B
M
t
I
c
S
e
t
0
hBrain Research Bulletin 89 (2012) 159– 167
Contents lists available at SciVerse ScienceDirect
Brain  Research  Bulletin
jo u r n al hom epage : www.elsev ier .com/ locate /bra inresbul l
esearch  report
-Phycocyanin  protects  SH-SY5Y  cells  from  oxidative  injury,  rat  retina  from
ransient  ischemia  and  rat  brain  mitochondria  from  Ca2+/phosphate-induced
mpairment
avier  Marín-Pridaa,  Giselle  Pentón-Rolb,  Fernando  Postalli  Rodriguesc,  Luciane  Carla  Alberici c,
arina  Stringhettad,  Andréia  Machado  Leopoldinod, Zeki  Naalc, Ana  Cristina  Morseli  Polizelloc,
lexey  Llópiz-Arzuagab, Marcela  Nunes  Rosae, José  Luiz  Liberatoe,  Wagner  Ferreira  dos  Santose,
ergio  Akira  Uyemurad,  Eduardo  Pentón-Ariasb,  Carlos  Curti c, Gilberto  L.  Pardo-Andreua,∗
Center for Research and Biological Evaluations, Institute of Pharmacy and Food, University of Havana, Ave. 23 e/214 y 222, PO Box 430, Havana, Cuba
Center for Genetic Engineering and Biotechnology, Ave. 31 e/158 y 190, PO Box 6162, Havana, Cuba
Department of Physics and Chemistry, Faculty of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ave. Café s/n, 14040-903 Ribeirão Preto, São Paulo, Brazil
Department of Clinical, Toxicological and Bromatological Analysis, Faculty of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ave. Café s/n,
4040-903 Ribeirão Preto, São Paulo, Brazil
Department of Biology, Faculty of Philosophy, Sciences, and Literature of Ribeirão Preto, University of São Paulo, Ave. Bandeirantes 3900, PO Box 14040-901,
ibeirão Preto, São Paulo, Brazil
 r  t  i  c  l  e  i  n  f  o
rticle history:
eceived 6 July 2012
eceived in revised form 9 August 2012
ccepted 30 August 2012
vailable online 7 September 2012
eywords:
-Phycocyanin
H-SY5Y
ransient rat retinal ischemia
at brain mitochondria
ntioxidant
a  b  s  t  r  a  c  t
Oxidative  stress  and  mitochondrial  impairment  are  essential  in  the  ischemic  stroke  cascade  and  even-
tually  lead  to  tissue  injury.  C-Phycocyanin  (C-PC)  has  previously  been  shown  to  have  strong  antioxidant
and  neuroprotective  actions.  In the  present  study,  we  assessed  the  effects  of  C-PC on  oxidative  injury
induced  by  tert-butylhydroperoxide  (t-BOOH)  in SH-SY5Y  neuronal  cells,  on  transient  ischemia  in rat
retinas,  and in  the calcium/phosphate-induced  impairment  of  isolated  rat  brain  mitochondria  (RBM).  In
SH-SY5Y cells,  t-BOOH  induced  a signiﬁcant  reduction  of cell  viability  as  assessed  by  an  MTT assay,  and
the  reduction  was  effectively  prevented  by  treatment  with  C-PC  in  the  low  micromolar  concentration
range.  Transient  ischemia  in  rat retinas  was  induced  by  increasing  the  intraocular  pressure  to 120  mmHg
for  45 min,  which  was  followed  by  15  min  of  reperfusion.  This event  resulted  in  a cell  density  reduction
to  lower  than  50%  in  the  inner  nuclear  layer  (INL),  which  was  signiﬁcantly  prevented  by  the  intraocu-
lar  pre-treatment  with  C-PC  for 15  min.  In the  RBM  exposed  to 3 mM  phosphate  and/or  100  M  Ca2+,europrotection C-PC  prevented  in  the  low  micromolar  concentration  range,  the  mitochondrial  permeability  transition  as
assessed  by  mitochondrial  swelling,  the  membrane  potential  dissipation,  the  increase  of reactive  oxygen
species  levels  and  the release  of  the  pro-apoptotic  cytochrome  c.  In  addition,  C-PC  displayed  a  strong
inhibitory  effect  against  an  electrochemically-generated  Fenton  reaction.  Therefore,  C-PC is a  potential
neuroprotective  agent  against  ischemic  stroke,  resulting  in reduced  neuronal  oxidative  injury  and  the
ia  froprotection  of mitochondrAbbreviations: t-PA, tissue plasminogen activator; C-PC, C-Phycocyanin; t-
OOH, tert-butylhydroperoxide; RBM, rat brain mitochondria; DMEM, Dulbecco’s
odiﬁed Eagle Medium; MTT, 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-
etrazolium bromide; PBS, phosphate buffered saline; DMSO, dimethyl sulfoxide;
OP, intraocular pressure; INL, inner nuclear layer; EGTA, ethylene gly-
ol tetraacetic acid; HEPES, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid;
IM, standard incubation medium; H2DCFDA, dichlorodihydroﬂuorescein diac-
tate; DCF, dichloroﬂuorescein;  , mitochondrial membrane potential; TPP+,
etraphenylphosphonium; MPT, mitochondrial permeability transition.
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1. Introduction
Ischemic stroke remains a major cause of death and disability
worldwide (Mukherjee and Patil, 2011; WHO, 2011). Although sig-
niﬁcant progress has been made to clarify the mechanisms involved
in the ischemic stroke cascade, the development of new and effec-
tive treatments has been largely unsuccessful. Thrombolysis with
tissue plasminogen activator (t-PA) is currently the only approved
human pharmacological treatment, but it is restricted to a minority
Open access under the Elsevier OA license.of patients due to its short therapeutic window (4.5 h) (Fonarow
et al., 2011; Maiser et al., 2011). An alternative approach known
as neuroprotection has been focused on protecting the neurovas-
cular unit by blocking the main pathogenic processes that causes
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schemic injury (Ginsberg, 2008). Reactive oxygen species (ROS)
enerated soon after ischemia, during reperfusion and thereafter
re considered crucial mediators of ischemic injury (Saito et al.,
005). Mitochondria, an important source of ROS, contribute sig-
iﬁcantly to the elevation of these oxidants after an ischemic event
Allen and Bayraktutan, 2009). Thus, antioxidant-based neurovas-
ular protective strategies may  be potential treatments to expand
he number of currently approved therapies (Jung et al., 2010).
Previous studies have demonstrated that C-Phycocyanin (C-
C), the main phycobiliprotein of cyanobacteria Spirulina platensis,
xerts potent antioxidant, anti-inﬂammatory and neuroprotective
ctions in different experimental conditions (Romay et al., 2003).
hycobiliproteins are light-harvesting complexes composed of
po-proteins covalently attached to open chain tetrapyrrole chro-
ophores, named phycocyanobilins. C-PC has  and  polypeptides
ubunits (18–20 kDa) (Pentón-Rol et al., 2011a); one phyco-
yanobilin is attached at cysteine 84 in the -chain and two
hycocyanobilins are attached at cysteines 84 and 155 in the
-chain (Padyana et al., 2001; Pentón-Rol et al., 2011a).  Recent
esults from our group have shown that the administration of
-PC either prophylactically or therapeutically exhibited bene-
cial effects against global cerebral ischemia–reperfusion injury
n gerbils (Pentón-Rol et al., 2011a).  These effects were partially
xplained by the C-PC ability to counteract oxidative damages.
In the present study, we characterized the in vitro protective
ffects of C-PC against tert-butylhydroperoxide (t-BOOH)-induced
xidative injury in the SH-SY5Y human neuroblastoma cell line and
n vivo against transient ischemia in rat retinas. The effects of C-PC
ere also examined in isolated rat brain mitochondria (RBM) with
 Ca2+/phosphate overload, a condition that mimics the mitotoxic
nvironment that results from an ischemic injury.
. Materials and methods
.1. Reagents and compounds
All chemicals used were of the highest grade available and purchased from
igma–Aldrich (St. Louis, MO,  USA) unless otherwise speciﬁed. C-PC was  puriﬁed
y  ionic exchange, as previously described (Pentón-Rol et al., 2011a). An A620/A280
bsorbance ratio of 4.58 was obtained, indicative of higher than 90% purity (Patil and
aghavarao, 2007). C-PC was  dissolved in sterile phosphate-buffered saline (PBS)
H  7.2, ﬁltered through a 0.2 m syringe ﬁlter under sterile conditions (Sartorius
inisart® , Germany) and stored in the dark at 4 ◦C until use.
.2. Animals
Rats were obtained from the Animal Breeding Center at the Ribeirão Preto Cam-
us, University of São Paulo (USP). The animals were maintained under standard
aboratory conditions (60% humidity, 22 ± 1 ◦C, and 12 h light/darkness cycle) with
ree access to food and water. All procedures were performed in compliance with
he USP guidelines and with the European Communities Council Directive of 24
ovember 1986 (86/609/EEC) for animal experimentation.
.3. Cell culture
SH-SY5Y human neuroblastoma cells (Rio de Janeiro Cell Bank, Brazil) were
xpanded in Dulbecco’s Modiﬁed Eagle Medium (DMEM, Gibco, USA) containing 10%
etal bovine serum (Gibco, USA), 100 IU/mL penicillin G, 100 g/mL streptomycin
nd  0.25 g/mL amphotericin B at 37 ◦C in 5% CO2/95% air. The medium was changed
very two days, and the cells were subcultured every four days by trypsinization and
e-plated in T-25 or T-75 ﬂasks (5 or 15 mL  ﬁnal volume, respectively) (BD Falcon,
SA) at 4 × 105 cells/mL.
.4. Cell treatment and viability assay
SH-SY5Y cells between passages three and seven were cultured in quadrupli-
ate  in 96 wells plates (BD Falcon, USA) at 4 × 104 cells/200 L/well for 24 h. The
ells were incubated with freshly prepared t-BOOH in complete medium at different
oncentrations for 6 h, or pre-treated with C-PC for 24 h followed by the incubation
ith fresh medium containing C-PC and 25 M t-BOOH for another 6 h. Cell viability
as  measured by the quantity of blue formazan products obtained from the color-
ess 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) by
itochondrial dehydrogenases, which are only active in viable cells. After the incu-
ation time, the cells were gently washed with sterile phosphate buffered saline Bulletin 89 (2012) 159– 167
(PBS) pH 7.2 (200 L/well), and MTT  (freshly prepared at 0.5 mg/mL in serum-free
medium) was added at 200 L/well and incubated for 4 h at 37 ◦C. After MTT  with-
drawal, 200 L of dimethyl sulfoxide (DMSO) was  added to each well to solubilize
the  formazan crystals, and the absorbance of each well was measured at 570 nm in
a  microplate reader (Varian Cary 50, Australia). The results were expressed as the
percent of absorbance relative to the undamaged control cells.
2.5. Induction of transient retinal ischemia
A  transient ischemia in the rat retina was induced as previously described, with
some modiﬁcations (Beleboni et al., 2006). Male Wistar rats weighing 250–300 g at
the time of surgery (n = 5 per group) were anesthetized with 450 mg/Kg i.p. uret-
hane  (Acrôs Organic, USA) (Meyer, 2008), and the anterior chamber of the left eye
was cannulated with a 27-gauge needle attached to a manometer, a pump and an
air  reservoir. The intraocular pressure (IOP) was raised to 120 mmHg for 45 min.
Afterwards the needle was withdrawn, and the IOP was  normalized for a 15 min
reperfusion period. The drug was intraocularly injected 15 min  prior to the ischemic
insult. The vehicle group was  injected with sterile PBS at pH 7.2. The right-side,
untouched retinas served as control (n = 10).
2.6. Histological assessment
After the reperfusion period, the animals were sacriﬁced, and both eyes were
rapidly enucleated, placed in the ﬁxation solution (25.5 mL  ethanol 80%, 3 mL
formaldehyde 37% and 1.5 mL  glacial acetic acid) for 24 h and transferred to 80%
ethanol for another 4 days (Krinke, 2000). The dissected retina was dehydrated in
graded ethanol and xylene and embedded in parafﬁn. Retinas were sectioned at
5  m,  approximately 1 mm from the optic nerve, and stained with hematoxylin and
eosin. For each experimental group, ﬁve microscopic ﬁelds (magniﬁcation 400×)
of  one sagittal section of a retina were captured by a digital camera (DFC300 FX,
DM 5000 B microscope, Q-Win software, Leica Microsystems, Germany). The num-
ber  of viable cells, those that were not eosinophilic, was manually counted in the
established areas (200 m × 50 m) of the inner nuclear layer (INL) using ImageJ
1.41 software (National Institutes of Health, USA). Cells showing atrophy, shrinkage,
nuclear pyknosis, dark cytoplasmic coloration or ambient empty spaces were con-
sidered damaged (Beleboni et al., 2006). The results were expressed as a percentage
of  the number of viable cells in the control retinas.
2.7. Isolation of rat brain mitochondria
Mitochondria were isolated as previously described, with minor modiﬁcations
(Mirandola et al., 2010). Brieﬂy, two male Wistar rats weighing 200–240 g were sac-
riﬁced by decapitation, and their brains were rapidly removed and placed in 10 mL
of  ice-cold isolation buffer (225 mM mannitol, 75 mM sucrose, 1 mM ethylene gly-
col  tetraacetic acid (EGTA), 0.1% de-fatted bovine serum albumin (BSA), and 10 mM
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES); pH 7.2). The olfac-
tory bulb, cerebellum and underlying regions were discarded, and the remaining
forebrains were split using surgical scissors and washed twice in isolation buffer.
The  brain tissue was  manually homogenized in 20 mL of the isolation buffer using a
glass Dounce homogenizer (20–25 strokes). The homogenate was centrifuged at 4 ◦C
(2000 × g, 3 min) in a Hitachi RT15A5 rotor (Japan), and the resulting supernatant
was further centrifuged (12,000 × g, 8 min). The pellet was gently resuspended in
10  mL  of isolation buffer containing 20 L of 10% digitonin (to induce synaptosomal
lysis) using a ﬁne-tipped brush and centrifuged at 12,000 × g for 10 min. The dark
pellet was resuspended in 10 mL  of isolation medium without EGTA and BSA and
centrifuged again (12,000 × g, 10 min), and the resulting pellet was resuspended in
200 L of standard incubation medium (SIM: 225 mM mannitol, 75 mM sucrose,
and  10 mM K+HEPES; pH 7.2). The total protein concentration was determined by
the  Biuret method with BSA as a standard and was approximately 30–50 mg/mL for
each  preparation. All procedures were performed at 4 ◦C.
2.8.  Mitochondrial assays
The experiments using isolated RBM were performed at 30 ◦C with continuous
magnetic stirring in the SIM described above. The respiratory control ratio (state
3/state 4 respiratory rates) was over 4; this ratio was  determined after monitoring
oxygen consumption with an oxygraph equipped with a Clark-type oxygen electrode
(Hansatech Instruments Ltd., UK) and with 1 mg/mL of RBM plus 5 mM succinate,
2  M rotenone, 800 M ADP and 2 mM KH2PO4. Oligomycin at 1 g/mL was used
at  state 4. Mitochondrial swelling was estimated from the decrease in the apparent
absorbance at 540 nm using a Model U-2910 Hitachi spectrophotometer (Japan).
ROS generation in RBM was monitored using 2 M of dichlorodihydroﬂuorescein
diacetate (H2DCFDA) (Invitrogen, Life Technology Co., USA). The changes in the
ﬂuorescence of the DCF product were monitored using an F-4500 ﬂuorescence spec-
trophotometer (Hitachi, Japan) at 503/529 nm excitation/emission wavelengths,
and data were expressed as differences with respect to the initial value (Esposti,
2002; Rodrigues et al., 2011). The mitochondrial membrane potential ( ) was
estimated by continuously monitoring the concentration of the lipophilic cation
tetraphenylphosphonium chloride (TPP+) in the extramitochondrial medium (Ross
et al., 2005) with a TPP+ selective electrode (World Precision Instruments Inc., USA)
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Fig. 1. Protective effects of C-PC against oxidative injury in SH-SY5Y human
neuroblastoma cells. (A) Viability of cells exposed to different concentrations of
tert-butylhydroperoxide (t-BOOH) for 6 h. (B) Effects of a pre-treatment with C-PC
for  24 h followed by a co-incubation with 25 M of t-BOOH for 6 h. Trolox (500 M)
was  used as a control antioxidant. Cell viability was assessed by an MTT  assay andJ. Marín-Prida et al. / Brain Re
onnected to the oxygraph. For the calculation of  , the matrix volume of the
BM was  assumed to be 1.5 L/mg protein. The membrane potential was calcu-
ated assuming that the TPP+ distribution between the mitochondria and medium
ollowed the Nernst equation. Corrections were made as previously described for
he binding of TPP+ to the mitochondrial membrane (Jensen et al., 1986). Data were
xpressed as a percentage of  in relation to the level reached before Ca2+addition.
.9. Assessment of the release of cytochrome c from mitochondria
The release of cytochrome c was assessed in the same conditions as used in
he  swelling experiments. The mitochondrial suspension was  centrifuged (9000 × g,
 min) at 4 ◦C, and the supernatant (100 L) was  supplemented with 2 L of protease
nhibitor cocktail (Sigma–Aldrich, USA), incubated with 25 L of loading buffer (50%
lycerol, 10% SDS, 0.05% bromophenol blue, 25% mercaptoethanol) at 95 ◦C for 5 min,
ubjected to 12% SDS-PAGE and transferred to a nitrocellulose membrane. A mouse
onoclonal antibody against cytochrome c (1:1000, BD Biosciences Pharmingen,
SA), a mouse-speciﬁc secondary antibody conjugated with horseradish peroxidase
1:1000, Santa Cruz Biotechnology, USA) and the ECLTM Systems (GE HealthCare, UK)
ere  used for detection. The ﬁlms were placed in a digital ﬂatbed scanner (HP Scanjet
770, USA) for image acquisition. Densitometry was performed using the ImageJ
.41  software (National Institutes of Health, USA). The results were presented as a
ercent of the Ca2+/phosphate damaged controls.
.10. Electrochemical assays
Electrochemical assays were conducted with a BAS CV-27 potentiostat (Bio-
nalytical System, Inc., USA) using conventional electrochemical cells with three
lectrodes and an Omnigraphic 100 recorder (Texas Instruments, USA). A glassy
arbon electrode with a 0.0314 cm2 area, polished with a 1 m alumina–water
uspension and rinsed thoroughly with water and acetone was used as working
lectrode. A platinum wire was used as the counter electrode, and all potentials
ere referenced to a [Ag/AgCl/KCl (sat)] electrode without regard for the liquid junc-
ion potential. The electrolyte supporting solution was  obtained by mixing 100 mM
Cl and 100 mM chloroacetic acid pH 3.3, and Fe3+-EDTA (0.1 mM)  was formed from
quimolar additions of Fe(NO3)3 and Na2H2EDTA. The 100 mM hydroperoxide stock
olution was  prepared by dissolving 30% H2O2 in the electrolyte supporting solution.
ach sample was  deoxygenated with argon for 20 min  before performing electro-
hemical measurements. Cyclic voltammetry was conducted at a ﬁnal volume of
.0 mL  for all experiments with a potential sweep rate of 30 mV/s and a potential
indow between −0.4 V and 0.4 V. Control experiments were measured in ESS in
he  presence of Fe3+-EDTA or H2O2, in the presence of both and without C-PC or oxy-
en  (Argon purge). The voltammetric backgrounds were measured in the presence
f Fe3+-EDTA but in the absence of any peroxides or oxygen (N2 purge).
.11. Statistical analysis
The software program GraphPad Prism 5.0 (GraphPad Software Inc., USA) was
sed  for statistical analysis. The data were expressed as the mean ± SEM. Com-
arisons between the different groups were performed by the one-way analysis
f  variance (ANOVA) followed by the Newman–Keuls multiple comparison test.
ifferences were considered statistically signiﬁcant at p < 0.05.
. Results
.1. C-PC protected SH-SY5Y cells from t-BOOH-induced death
Fig. 1A shows that the viability of SH-SY5Y cells was signiﬁcantly
educed after exposing them to t-BOOH, and pre-treatment with C-
C prevented this effect (Fig. 1B). C-PC at 50 M almost completely
revented the cell viability reduction and did not present cyto-
oxic effects, demonstrating the safety of the compound. This result
emonstrates that C-PC has a protective effect against the oxida-
ive neurotoxic injury induced by t-BOOH. We  have used Trolox,
 water-soluble analogue of vitamin E, as a control antioxidant to
how that ROS play a major role in t-BOOH cytotoxicity in SH-SY5Y
ells (Lee et al., 2000).
.2. C-PC protected rat retinas from transient ischemia
To assess whether C-PC protects neuronal viability against a
ocal stroke in vivo, we performed a proof-of concept experiment for
ransient ischemia in rat retinas. Fig. 2 shows that the rat retina was
ighly susceptible to an ischemia–reperfusion injury primarily at
he INL in our experimental conditions, which exhibited less than a
0% reduction in viable cells; neuronal death was also accompaniedexpressed as a percent of the control. Data are presented as the mean ± SEM of
three independent experiments. Different letters: p < 0.05 according to the ANOVA
and post hoc Newman–Keuls tests.
by edema and layer disorganization. Pre-treatment with C-PC pre-
vented INL cell loss, indicating that C-PC not only protects neurons
in vitro, but also in in vivo ischemic conditions.
3.3. C-PC prevented the mitochondrial permeability transition in
RBM
A key pathogenic event in a stroke is the opening of pores in the
inner mitochondrial membrane; the mitochondrial permeability
transition (MPT) (Hirsch et al., 1998). In the next set of experi-
ments, we assessed the effect of C-PC on the MPT  as estimated by
the swelling of the RBM induced by Ca2+ and inorganic phosphate
(Pi), as previously described (Berman et al., 2000) (Fig. 3A). Compar-
isons among the initial decreases in the slopes of the absorbances
at 540 nm revealed that C-PC prevented MPT  in the low micromo-
lar concentration range (Fig. 3B). This suggests that the inhibition
of MPT  is involved in the mechanisms that are responsible for the
C-PC neuroprotective effects.
3.4. C-PC prevented an increase in ROS levels in RBM
MPT  has been associated with an increase in ROS levels in
brain mitochondria (Maciel et al., 2001). Our results showed that
Ca2+ overload induced a signiﬁcant increase in ROS levels in RBM
(Fig. 4A), and pre-treatment with C-PC at low micromolar concen-
tration range prevented this effect (Fig. 4B).
3.5. C-PC prevented   dissipation in RBMTo assess the effect of C-PC on Ca2+-promoted  dissipation,
RBM were pre-incubated with 30 M of C-PC for approximately
10 min, and then 100 M of Ca2+ was  added (Fig. 5). Ca2+ overload
produced a  dissipation of approximately 30%; this dissipation
162 J. Marín-Prida et al. / Brain Research Bulletin 89 (2012) 159– 167
Fig. 2. Histological evaluation (hematoxylin and eosin staining) of the effects of C-PC on transient ischemia in rat retinas. The panels show representative photographs of
the  sagittal sections of retina from undamaged controls (A), and retinas that underwent ischemia–reperfusion (I-R) treated with vehicle (B), 10 M C-PC (C), 50 M C-PC (D)
or  100 M C-PC (E). Morphometric analysis of INL regions is shown in (F). Different letters: p < 0.05 according to the ANOVA and post hoc Newman–Keuls tests. ONL: outer
nuclear layer, OPL: outer plexiform layer, INL: inner nuclear layer, IPL: inner plexiform layer and GCL: ganglion cell layer. Scale bar: 50 m.
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Fig. 3. Effects of C-PC on mitochondrial swelling induced by Ca2+/phosphate. RBM
(1  mg/mL) were pre-incubated for 5 min  at 30 ◦C with C-PC in SIM with 5 mM succi-
nate  and 2 M rotenone followed by the addition of 100 M CaCl2 (Ca2+) for another
1  min. Then, 3 mM KH2PO4 (Pi) was added to the mitochondrial suspension, and
absorbance was monitored at 540 nm for 10 min  (A). The rates of swelling (slope of
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Fig. 4. Effects of C-PC on the increase in mitochondrial ROS levels induced by Ca2+.
The RBM (1 mg/mL) were incubated for 5 min at 30 ◦C in SIM plus C-PC, 5 mM suc-
cinate, 2 M rotenone, 3 mM KH2PO4 (Pi) and 2 M H2DCFDA, and ﬂuorescence
monitoring was then initiated. After 5 min, 100 M CaCl2 (Ca2+) was  added to the
suspension, which was monitored for another 10 min (A). Comparisons in ﬂuores-
cence intensity were made at this point (B). Data are expressed as the mean ± SEM for
three independent experiments. Different letters: p < 0.05 according to the ANOVA
and post hoc Newman–Keuls tests.
Fig. 5. Effects of C-PC on  dissipation induced by Ca2+. Effects in the absence (A)
or  presence of 30 M C-PC (B), in the presence of 1 M of cyclosporine A (CsA, C), and
the % of   dissipation after Ca2+ addition (insert). The  values before and after
Ca2+ addition for (A), (B) and (C), in mV,  were: −154.06 ± 4.43 and −108.90 ± 3.14;
−153.49 ± 2.81 and −143.96 ± 2.17; and −159.52 ± 4.12 and −153.83 ± 5.26, respec-
tively. The RBM (2 mg/mL) were incubated in 1 mL  of SIM with 5 mM succinate andhe decrease in absorbance in the ﬁrst 5 min  after Pi addition) were compared (B).
ata  are expressed as the means ± SEM of at least three independent experiments.
ifferent letters: p < 0.05 according to the ANOVA and post hoc Newman–Keuls tests.
as effectively prevented by treatment with either C-PC or the
lassical MPT  inhibitor cyclosporin A (Fig. 5).
.6. C-PC prevented mitochondrial cytochrome c release in RBM
Cytochrome c release from mitochondria plays an important
ole in cell death (Li et al., 1997). Our results showed that C-
C prevented the oxidative stress-induced cell viability decrease
n SH-SY5Y cells (Fig. 1). To assess the potential involvement of
ytochrome c release inhibition in this effect, we used Western blot
o detect the free cytochrome c in the supernatant fraction obtained
fter the mitochondrial swelling experiments (Fig. 6). The Ca2+/Pi-
verload induced a substantial release of cytochrome c from RBM,
ut this release was prevented by C-PC at low micromolar concen-
rations. The effect of C-PC was signiﬁcantly higher than the effect
f the antioxidant Trolox.
.7. C-PC inhibited the Fenton reaction
H2O2 is regarded as a key mediator in oxidative stress because
t is highly stable under physiological conditions (Bergendi et al.,
999). When reacting with metals such as iron, H2O2 yields
 hydroxyl through the Fenton reaction (Winterbourn, 1995).
ydroxyls are highly reactive radicals that can initiate lipid
2  M rotenone in the presence or the absence of C-PC; this was  performed after
the addition (indicated by the arrows) of both 0.5 M TPP+ at a 1.5 M ﬁnal con-
centration and 100 M CaCl2 (Ca2+). Data are expressed as the mean ± SEM of three
independent experiments. Different letters: p < 0.05 according to the ANOVA and
post  hoc Newman–Keuls tests.
164 J. Marín-Prida et al. / Brain Research
Fig. 6. Effects of C-PC on the release of cytochrome c from mitochondria as
induced by Ca2+ and phosphate. Representative Western blots and densitometry
of  free cytochrome c following the incubation of RBM under swelling conditions.
Lane 1: control; lanes 2–5: Ca2+/Pi plus 5, 10, 15 M C-PC and 1 mM Trolox,
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tespectively; lane 6: Ca2+/Pi. Data are expressed as the mean ± SEM of three inde-
endent experiments. Different letters: p < 0.05 according to the ANOVA and post
oc Newman–Keuls tests.
eroxidation followed by membrane disorganization and rupture
Adibhatla and Hatcher, 2010). In this study, we assessed the effect
f C-PC on the Fenton reaction using an electrochemical approach
Laine and Cheng, 2009). Fig. 7 (trace a) shows a cyclic voltam-
ogram of the Fe3+-EDTA/Fe2+-EDTA oxidation–reduction process
hat can be represented by Eq. (1). Fig. 7 (trace b) shows the voltam-
etric behavior of Fe3+-EDTA in the presence of 4 mM H2O2. The
ig. 7. Effects of C-PC on the Fenton reaction. Cyclic voltammograms of the
eversible oxidation–reduction of Fe3+-EDTA/Fe2+-EDTA (a, Eq. (1)) and the elec-
rocatalytic reaction between Fe2+-EDTA and H2O2 in the absence (b, Eq. (2)) and in
he  presence of 0.38 mM C-PC (c). Solutions contain 100 mM KCl, 0.1 mM Fe3+-EDTA
nd 100 mM chloroacetic acid (pH 3.3). Cyclic voltammograms were performed in
he  absence of O2 by a prior nitrogen purge, at a scan rate of 100 mV/s, and with
 glassy carbon electrode (area 0.0314 cm2) as the working electrode. The typical
racings of three independent experiments are shown. Bulletin 89 (2012) 159– 167
intensity of the cathode current (arrowhead) was  substantially
increased (from −4 A to approximately −18 A), but that of the
anode was not. This indicates that a catalytic mechanism is involved
and could be ascribed to the Fenton reaction, represented by Eq. (2).
The C-PC in the reaction medium reduced the cathode current to
approximately −8 A (trace c), which represents approximately a
55% inhibition of the Fenton reaction.
4. Discussion
Oxidative stress is a crucial factor in the pathophysiology of
ischemic stroke and acts by either damaging cellular structures or
participating in signaling pathways (Saito et al., 2005). Compounds
inhibiting this neurotoxic process have been considered as promis-
ing therapeutic candidates against ischemic stroke (Broussalis et al.,
2012). C-PC was  shown to have a strong antioxidant activity in
several in vivo experiments, including global ischemia–reperfusion
damage in the brain (Pentón-Rol et al., 2011a)  and the heart
(Khan et al., 2006a),  doxorubicin-induced injury in cardiomyocytes
(Khan et al., 2006b), experimental autoimmune encephalomyeli-
tis (Pentón-Rol et al., 2011b),  atherosclerosis (Riss et al., 2007),
paraquat-induced lung damage (Sun et al., 2011), activated
platelets (Hsiao et al., 2005) and thymic atrophy (Gupta et al., 2011).
In vitro, C-PC prevents neurotoxic injury in cerebellar granule cells
during conditions of low potassium and serum deprivation (Rimbau
et al., 2001) and in SH-SY5Y human neuroblastoma cells subjected
to an environment of exogenous iron overload (Bermejo-Bescós
et al., 2008). In this study, we assessed the potential of C-PC to
protect the SH-SY5Y cell line from the oxidative damage induced
by the organic hydroperoxide t-BOOH (Chance et al., 1979). C-PC
protected the viability of the SH-SY5Y cells exposed to t-BOOH.
Iron can catalyze the conversion of t-BOOH to tert-butylperoxy
and tert-butoxy radicals, which initiate lipid peroxidation (Cadenas
and Sies, 1982). In primary rat cortical neurons, t-BOOH damage
was blocked by a pre-treatment with deferoxamine, an iron spe-
ciﬁc chelator, indicating the requirement of the intracellular pool
of iron for t-BOOH toxicity (Abe and Saito, 1998). Moreover, an
increased t-BOOH detoxiﬁcation activity by glutathione or thiore-
doxine peroxidases impaired the reductive effect of NAD(P)H on
glutathione and thioredoxine and decreased their capacities to
remove H2O2, particularly in mitochondria (Kowaltowski et al.,
2001). Indeed, it has been reported that t-BOOH induces a free
radical overproduction in SH-SY5Y cells (Amoroso et al., 1999).
Therefore, the potent action of C-PC in scavenging free radicals
(Bhat and Madyastha, 2000; Romay et al., 2000) and preserving
the endogenous antioxidant systems (Bermejo-Bescós et al., 2008),
together with a potential iron chelating capability, may  be related
to the neuroprotective effects of C-PC reported in this study.
Retinal ischemia induced by an IOP increase can produce dev-
astating visual impairment disorders such as glaucoma, which is
the second leading cause of blindness worldwide (Resnikoff et al.,
2004). The retina is highly sensitive to a transient blockade in blood
supply due to its active metabolism and high content of polyunsat-
urated fatty acids, and therefore, this tissue is very susceptible to
oxidative damage (Kuriyama et al., 2001). At the cellular level, accu-
mulating evidence indicates that both glutamate excitotoxicity and
oxidative stress are key mediators in ischemia–reperfusion injury
to retina (Bonne et al., 1998; Louzada-Junior et al., 1992; Osborne
et al., 2004), similar to the damage in an ischemic brain (Allen and
Bayraktutan, 2009; Lau and Tymianski, 2010). Therefore, retinal
ischemic damage is a suitable in vivo model to assess the protective
effects of compounds against focal ischemic stroke. To our knowl-
edge, the present study is the ﬁrst to reveal that C-PC prevents
neuron loss in rat retinas subjected to a transient ischemia. Because
oxidative stress may be strongly implicated in the pathogenesis
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f ischemic stroke (Allen and Bayraktutan, 2009), the scavenger
ctivities of C-PC against hydroxyl radicals (Romay et al., 1998), per-
xyl radicals (Lissi et al., 2000) and peroxynitrite anions (Bhat and
adyastha, 2001) may  be involved in C-PC preventing the neurode-
eneration of retinas after ischemia–reperfusion. Accordingly, our
esults showed an inhibitory effect of C-PC on the Fenton reaction
s measured by an electrochemical approach, and this inhibition
ay  be involved in the protection of retina tissue from ischemic
amage.
Mitochondria are both initiators and targets of oxidative dam-
ge, which impairs ATP production, induces MPT  and releases
ro-apoptotic factors (Sims and Anderson, 2002; Valko et al., 2007).
herefore, in this work, we also studied brain mitochondria as a
otential pharmacological target to explain the neuroprotective
ffects elicited by C-PC.
Under various conditions, such as in the presence of Ca2+ and
norganic phosphate, isolated mitochondria undergo MPT. This
rocess is characterized by a Ca2+-dependent increase in the per-
eability of the inner mitochondrial membrane, resulting in a 
issipation, mitochondrial swelling, and an eventual rupture of the
uter mitochondrial membrane (Zoratti and Szabo, 1995). MPT  is
ne of the proposed mechanisms for the release of mitochondrial
ro-apoptotic mediators, and its inhibition is a plausible phar-
acological target for therapeutic intervention in stroke (Kristal
t al., 2004). In our study, MPT  was induced by an overload of
a2+ in the presence of inorganic phosphate (Pi) and estimated by
he occurrence of RBM swelling. These conditions mimic  those of
schemic neurons, in which a rise in cytosolic Ca2+ and Pi concen-
rations due to excitotoxic glutamate and increased ATP hydrolysis,
espectively, both occur (Nicholls and Budd, 1998; Oliveira and
owaltowski, 2004). As a result of C-PC treatment, mitochondrial
welling, and therefore MPT, was signiﬁcantly prevented, and this
ay  constitute an important event contributing to the neuropro-
ective capability of C-PC.
Ischemia induces an abnormal increase in intracellular Ca2+
evels. This cation can cause mitotoxic effects through the acti-
ation of degradative and ROS-generating enzymes, which may
amage mitochondrial structures (Nakahara et al., 1992; Wingrave
t al., 2003). Accordingly, our results showed a signiﬁcant rise
n ROS levels in isolated RBM as a consequence of Ca2+/Pi over-
oad. The probe that we used for ROS detection, H2DCFDA, is a
embrane-permeable molecule that can be converted by mito-
hondrial matrix esterases to a non-ﬂuorescent H2DCF product
LeBel and Ischiropoulos, 1992). Although it is not actually a reliable
robe for superoxide and hydrogen peroxide, the most common
OS in biology, it is still widely used (Wardman, 2007). In the
resence of different radicals, such as hydroxyl, carbonate, nitro-
en dioxide (Wardman, 2007), and peroxynitrite (Jakubowski and
artosz, 2000), H2DCF is oxidized to the highly ﬂuorescent DCF
roduct. We  assumed that increased H2DCF oxidation reﬂects the
verall ROS status rather than any reactive species in particular.
herefore, the inhibitory effect of C-PC on mitochondrial ROS levels
ay  reﬂect its radical scavenging activity as a central mechanism
o protect mitochondria against oxidative injury. In this regard, it is
orth mentioning that in isolated guinea-pig brain mitochondria,
n the absence of nucleotides and respiratory chain inhibitors, H2O2
eneration was decreased by Ca2+ (Komary et al., 2008). However,
ifferences in the experimental conditions, tissues or species used
i.e. guinea-pig brain cortices against rat forebrains) may  inﬂuence
he characteristics of ROS production in brain mitochondria (Adam-
izi, 2005). Accordingly, mitochondrial complex I inhibition by
otenone stimulates ROS generation (Barrientos and Moraes, 1999;
iu et al., 2002; Votyakova and Reynolds, 2001) and Ca2+ strongly
ncreases ROS levels as detected with H2DCFDA in rotenone-treated
at forebrain mitochondria. Apparently, this increase is not associ-
ted with mitochondrial Ca2+ accumulation, but with Ca2+ acting Bulletin 89 (2012) 159– 167 165
on external sites of the inner mitochondrial membrane (Sousa et al.,
2003).
Our results also showed that major consequences of MPT  are
 dissipation and release of cytochrome c, which are associated
with oxidative damage to mitochondrial membranes (Brustovetsky
et al., 2002; Peng and Jou, 2010). These processes were inhibited by
CsA and Trolox, an MPT  blocker and a water-soluble antioxidant,
respectively, indicating that MPT  and the oxidative imbalance are
important in mitochondrial impairment. The protective effect of C-
PC on  and its inhibitory action on cytochrome c release may,
therefore, be indirectly caused by its strong antioxidant properties.
In conclusion, we demonstrated that C-PC is neuroprotective
both in vitro against t-BOOH-induced oxidative damage in the SH-
SY5Y human neuroblastoma cell line and in vivo in rat retina against
ischemia–reperfusion injury. In the isolated RBM, C-PC prevented
MPT, restored normal ROS levels, and prevented  dissipation
and cytochrome c release. These results indicate that mitochon-
drial protection may  be a mechanism involved in the effects of C-PC
against oxidative injury in neuronal cells.
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